Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07826923 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Acute Effects of tDCS on Musical Performance in Adolescent Instrumentalists

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 20% 30 → 24 participants
See other at-risk trials from Centro Universitário Augusto Motta

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reduced: 30 → 24 participants Show 5 more changesShow less
    • Start date pushed from Oct 1, 2026 to Oct 7, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
    • Study title revised
    • Eligibility criteria shortened, about 1 word
    • Study description shortened, about 4 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized, sham-controlled proof-of-concept study aims to investigate the safety, tolerability, and acute effects of transcranial direct current stimulation (tDCS) on musical performance in adolescent instrumentalists aged 12 to 16 years. Twenty-four participants will be randomly assigned to active or sham tDCS. Active stimulation will consist of 2.0 mA anodal tDCS applied for 30 minutes using 5 × 7 cm electrodes positioned over FCz and Fp2. Participants will perform the same previously learned instrumental musical piece or excerpt before stimulation, immediately after stimulation, and two hours after stimulation. Musical performances will be evaluated by blinded expert raters using a standardized performance rubric. Safety and tolerability will be monitored using a structured symptom checklist and predefined stopping criteria. Self-rated performance, nervousness, confidence, blinding, and protocol feasibility will also be explored.
Trial Details
NCT Number NCT07826923
Lead Sponsor Centro Universitário Augusto Motta
Collaborators: Neuromodulacao em Foco
Conditions
(from sponsor)		 Musical Performance, Neuromodulation
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov